Disease/Infection News

RSS

Scientist develops cryo-electron microscopy to clarify salmonellae structure

Bacteria like salmonellae infect their host cells by needle-shaped extensions which they create in large numbers during an attack. A group of Vienna-based scientists headed by Thomas Marlovits employed recently developed methods of cryo-electron microscopy and have been able to clarify the structure of this infection apparatus on the near-atomic scale.

4 Mar 2011

New discovery holds promise for TB treatment

New findings on how tuberculosis bacteria develop multi-drug tolerance point to ways TB infections might be cured more quickly.

4 Mar 2011

Nevirapine reduces HIV transmission risk from mother to breastfeeding infants by 75%

Giving breastfeeding infants of HIV-infected mothers a daily dose of the antiretroviral drug nevirapine for six months halved the risk of HIV transmission to the infants at age 6 months compared with giving infants the drug daily for six weeks, according to preliminary clinical trial data presented today.

4 Mar 2011

Researchers investigate why immune system is blunted after spinal cord injury

Mobility is a challenge for spinal cord injured patients. Infection is another. Adam Thrasher, assistant professor of health and human performance, says infection is the leading cause of death for people living with spinal cord injuries for two years or more.

4 Mar 2011

Protesters call on Indian government to reject free trade agreement with EU

Thousands of HIV-positive people from India and across Asia marched in New Delhi on Wednesday to protest the proposed free trade agreement between the European Union and India, "which has provisions that would restrict access to affordable medicines," the Times of India reports.

4 Mar 2011

AHF receives American Express fund to fight against HIV/AIDS

AIDS Healthcare Foundation is proud to announce that it has been voted as one of the charities to receive $200,000 in funding from American Express through the company's Members Project program.

4 Mar 2011

Ekomed to collaborate with Immune Network and Immunitor for further research of Immunoxel/Dzherelo

Immune Network Ltd. advises that Ukrainian company Ekomed LLC has agreed to collaborate with Immune Network and Immunitor for further clinical research of a tableted form of Ekomed's well-known immunomodulator herbal product Immunoxel/Dzherelo.

4 Mar 2011

ATS releases new report detailing emerging trends in HIV-linked pulmonary disease management

The American Thoracic Society has released a new report detailing recent global changes in the management of human immunodeficiency virus-associated pulmonary disease.

4 Mar 2011

Community gym surfaces do not appear to be reservoirs for MRSA transmission

Community gym surfaces do not appear to be reservoirs for MRSA transmission, according to a study published in the March issue of the American Journal of Infection Control, the official publication of APIC - the Association for Professionals in Infection Control and Epidemiology.

3 Mar 2011

Low vaccination rates across Australia

Vaccination rate figures show that older Australians are well protected against the flu but less so against pneumococcal disease and whooping cough. These figures were revealed by the Australian Institute of Health and Welfare (AIHW) and they show three-quarters of Australians aged 65 years and older had a flu shot in 2009. Just over half (55 per cent) were also vaccinated against pneumococcal disease.

3 Mar 2011

'Implementation science' approach to play a critical role in next phase of PEPFAR program

An "implementation science" approach will play a critical role in the next phase of The U.S. President's Emergency Plan for AIDS Relief, according to an editorial in JAIDS: Journal of Acquired Immune Deficiency Syndromes. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

3 Mar 2011

Positive outcomes from Argos AGS-004 Phase 2a trial in patients with HIV

Argos Therapeutics announced today that its Arcelis immunotherapy for the treatment of HIV, AGS-004, demonstrated positive outcomes with the primary endpoint of viral load control and a favorable safety and immunogenicity profile in a final analysis of a Phase 2a clinical trial.

3 Mar 2011

Study reveals expansion of NK cells after acute infection

The natural killer cells of our immune defense are activated for an extended period after the acute infection, which challenges the prevailing view that the elevation and activation of cells quickly pass.

3 Mar 2011

Lancet Infectious Diseases examines how resource gaps are creating barriers to reduce child mortality

The Lancet Infectious Diseases' Newsdesk examines how resource gaps in immunizations, health workers and financing are creating barriers to efforts to achieve the U.N. Millennium Development Goal target to reduce child mortality by two-thirds by 2015, as highlighted in a recent Save the Children report.

3 Mar 2011

New Sanitized MedX 200s active ingredient series to reduce risk of HAI

The new Sanitized MedX 200s active ingredient series, which has been used with success in the plastics of medical equipment, makes a contribution to reducing the risk of Healthcare-Associated Infections, HAI.

3 Mar 2011

Vertex announces positive interim results from telaprevir Phase 2 study in patients with HCV, HIV

Vertex Pharmaceuticals Incorporated announced today interim results from an ongoing, two-part, Phase 2 study evaluating telaprevir in combination with pegylated-interferon and ribavirin compared to pegylated-interferon and ribavirin alone in people who are infected with both genotype 1 hepatitis C virus and human immunodeficiency virus, also known as HCV-HIV co-infection.

3 Mar 2011

Adherence counseling during HIV treatment greatly improves patient outcomes

Intensive adherence counseling around the time of HIV treatment initiation significantly reduces poor adherence and virologic treatment failure in sub-Saharan Africa, according to a recent study in PLoS Medicine by Dr. Michael Chung, assistant professor of Global Health at University of Washington, who works at the Coptic Hope Center for Infectious Diseases in Nairobi, Kenya.

3 Mar 2011

Disease/Infection News

Scientist develops cryo-electron microscopy to clarify salmonellae structure

New discovery holds promise for TB treatment

Nevirapine reduces HIV transmission risk from mother to breastfeeding infants by 75%

Researchers investigate why immune system is blunted after spinal cord injury

Protesters call on Indian government to reject free trade agreement with EU

AHF receives American Express fund to fight against HIV/AIDS

Ekomed to collaborate with Immune Network and Immunitor for further research of Immunoxel/Dzherelo

ATS releases new report detailing emerging trends in HIV-linked pulmonary disease management

Community gym surfaces do not appear to be reservoirs for MRSA transmission

Low vaccination rates across Australia

'Implementation science' approach to play a critical role in next phase of PEPFAR program

Positive outcomes from Argos AGS-004 Phase 2a trial in patients with HIV

Study reveals expansion of NK cells after acute infection

Lancet Infectious Diseases examines how resource gaps are creating barriers to reduce child mortality

New Sanitized MedX 200s active ingredient series to reduce risk of HAI

Vertex announces positive interim results from telaprevir Phase 2 study in patients with HCV, HIV

Adherence counseling during HIV treatment greatly improves patient outcomes

Vical receives EMA Scientific Advice for Phase 3 trial of TransVax therapeutic CMV vaccine

Study demonstrates neuronal loss during initial stages of HIV infection in mouse model

Patients with end-stage renal disease who opt for PD experience no greater risk of catheter infection

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News